IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 217 filers reported holding IMMUNOGEN INC in Q2 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $224,783 | -16.7% | 14,164 | -0.9% | 0.00% | -25.0% |
| Q2 2023 | $269,690 | +472.6% | 14,292 | +16.5% | 0.00% | +300.0% |
| Q1 2023 | $47,098 | -22.6% | 12,265 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $60,834 | +4.9% | 12,265 | +1.5% | 0.00% | 0.0% |
| Q3 2022 | $58,000 | +11.5% | 12,080 | +4.2% | 0.00% | 0.0% |
| Q2 2022 | $52,000 | +6.1% | 11,594 | +13.5% | 0.00% | 0.0% |
| Q1 2022 | $49,000 | -29.0% | 10,216 | -2.6% | 0.00% | 0.0% |
| Q2 2021 | $69,000 | – | 10,494 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
| Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
| Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
| Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
| PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
| Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
| BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
| SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
| ClearBridge Investments | 14,428,856 | $55,840,000 | 0.06% |